Immunopathogenesis and immunotherapy in AIDS virus infections
about
An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cells.Current Advances in Virus-Like Particles as a Vaccination Approach against HIV InfectionHIV/AIDS vaccines for Africa: scientific opportunities, challenges and strategiesThe Curious Case of Type I IFN and MxA: Tipping the Immune Balance in AIDSRestoring function in exhausted CD8 T cells during chronic viral infectionAccurately measuring recombination between closely related HIV-1 genomesAmplified transmission of HIV-1: missing link in the HIV pandemicAntigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection.Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factorFully differentiated HIV-1 specific CD8+ T effector cells are more frequently detectable in controlled than in progressive HIV-1 infection.Generation and characterization of a defective HIV-1 Virus as an immunogen for a therapeutic vaccine.The antigenic determinants on HIV p24 for CD4+ T cell inhibiting antibodies as determined by limited proteolysis, chemical modification, and mass spectrometry.Impact of HIV on cell survival and antiviral activity of plasmacytoid dendritic cellsInhibition of adaptive immune responses leads to a fatal clinical outcome in SIV-infected pigtailed macaques but not vervet African green monkeys.HIV vaccination: turning the spotlight on effector memory T cells as mucosal gatekeepers.Toward development and production of human T cells in swine for potential use in adoptive T cell immunotherapy.Defective plasmacytoid dendritic cell-NK cell cross-talk in HIV infection.Genital tuberculosis as the cause of tuboovarian abscess in an immunosuppressed patient.H-2 Kd-restricted hepatitis B virus-derived epitope whose specific CD8+ T lymphocytes can produce gamma interferon without cytotoxicitySuppression of adaptive immune responses during primary SIV infection of sabaeus African green monkeys delays partial containment of viremia but does not induce disease.Enhanced immunogenicity of gp120 protein when combined with recombinant DNA priming to generate antibodies that neutralize the JR-FL primary isolate of human immunodeficiency virus type 1.Adoptive immunotherapy of feline immunodeficiency virus with autologous ex vivo-stimulated lymphoid cells modulates virus and T-cell subsets in blood.Immunization with a Mixture of HIV Env DNA and VLP Vaccines Augments Induction of CD8 T Cell Responses.Comparison of the genetic recombination rates of human immunodeficiency virus type 1 in macrophages and T cellsHIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activationSimian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNABroad cross-clade T-cell responses to gag in individuals infected with human immunodeficiency virus type 1 non-B clades (A to G): importance of HLA anchor residue conservation.Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12.In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles.HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation.Fetal exposure to HIV-1 alters chemokine receptor expression by CD4+T cells and increases susceptibility to HIV-1.Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease.Current progress in the development of a prophylactic vaccine for HIV-1.CD4 on CD8(+) T cells directly enhances effector function and is a target for HIV infection.Cell-intrinsic transforming growth factor-beta signaling mediates virus-specific CD8+ T cell deletion and viral persistence in vivoEnhancing SIV-specific immunity in vivo by PD-1 blockade.A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication.HIV-1 infected monozygotic twins: a tale of two outcomesExhaustion of tumor-specific CD8⁺ T cells in metastases from melanoma patients
P2860
Q25256583-884011FC-90D2-4A01-BB78-DFD8D90EB184Q26775082-DC210315-C0E0-4E51-8010-1DDE835C2211Q26799624-1F131218-1D73-442A-A7B7-39266D58E2EEQ26995244-8E345783-0D2A-4993-8683-A54FFB984C93Q28289222-23634AD3-4204-4BF4-A126-3B102BA8BC37Q28473807-F4701143-2192-45B5-8D6C-A15CD2FFEDE6Q30369759-D0CF4877-A4EF-44C6-B441-FEC809619B74Q30433900-3C5057D1-985E-4857-AD6F-7338A41FE0B2Q30448451-61B28E19-8853-47A4-9F12-5A24CFDEF085Q30830619-7D58F30F-F1C1-4D04-B952-3871132DD557Q31106756-729510F4-E1A2-49E7-B5AC-0A025B01E765Q33252188-251910AE-7890-4D70-A34C-88DBBF5C998EQ33285471-E5B1C61A-2D24-4936-B3F3-4C360928AF79Q33518502-211B0B96-7BC9-4F08-99F4-7A70733ADC5BQ33565035-90BCA694-D8E3-45C2-958A-70605E75B11AQ33606412-093E87A8-655F-45F2-B79A-1D650D192E53Q33686528-133C1F49-C6BF-4B8E-B3EA-1DD528D014B6Q33712864-9D100EF9-641B-4C94-A9EA-25411E871392Q33754985-E220A72F-B8E5-4E02-9DF8-347A8B03408FQ33806000-EBC7CE39-ABFB-47D4-ADCF-91AC526B310AQ33843103-B354D114-4253-4484-A9A1-00B6B1BBE374Q33856528-0F91F3A1-0EAC-4F74-A9A8-FB762EB1C6B8Q33876108-D3507C50-37C2-4BD4-B184-78AC88B377D7Q33883831-93D97075-BF96-4569-8751-3B081115F189Q33892217-BA77B98F-8B97-4143-8A4C-B83E7C7966EEQ33893665-113320FB-D2F3-4942-A290-752D8C3BBD88Q33930297-B4140C13-004F-4E96-AFA1-A75209D64C89Q34007084-EEE39731-0B64-4287-8D55-C5D6AE42A3D8Q34015978-39C34178-D502-413A-A6AB-E0B63A0AE489Q34234901-9B9AC5C1-39C8-4130-99BA-94F3919D2B94Q34336762-5A7E819A-2282-418E-91CA-97598FAB576FQ34397109-2512BA9B-28F7-40CC-80CE-F89BF86B0383Q34487847-BB257633-BEAA-48B6-9BF3-5A26EE01A9E7Q34502108-D6F59446-6FD5-4BB1-AF34-BB504EB0D79AQ34514930-9C76A7E2-8B91-4FEA-BA7F-756C0578CD18Q34577200-4B99C2C5-AB3A-4E70-9B86-4E7141CC39D0Q34601856-40F655D7-57E9-492C-B254-825924608BA6Q34646987-80AD2C37-8326-422A-BBB8-F8326DFF4EEAQ34761249-3F22FB3A-53D9-4B97-9C53-722D4A5CDDF5Q35015778-962E353B-4E4B-4F6E-8401-0F58070075EA
P2860
Immunopathogenesis and immunotherapy in AIDS virus infections
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Immunopathogenesis and immunotherapy in AIDS virus infections
@ast
Immunopathogenesis and immunotherapy in AIDS virus infections
@en
Immunopathogenesis and immunotherapy in AIDS virus infections
@nl
type
label
Immunopathogenesis and immunotherapy in AIDS virus infections
@ast
Immunopathogenesis and immunotherapy in AIDS virus infections
@en
Immunopathogenesis and immunotherapy in AIDS virus infections
@nl
prefLabel
Immunopathogenesis and immunotherapy in AIDS virus infections
@ast
Immunopathogenesis and immunotherapy in AIDS virus infections
@en
Immunopathogenesis and immunotherapy in AIDS virus infections
@nl
P921
P356
P1433
P1476
Immunopathogenesis and immunotherapy in AIDS virus infections
@en
P2093
Norman L Letvin
P2888
P356
10.1038/NM0703-861
P407
P577
2003-07-01T00:00:00Z
P5875
P6179
1023625665